Cargando…

Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key?

Detalles Bibliográficos
Autores principales:	Willimsky, Gerald, Protzer, Ulrike, Knolle, Percy, Heikenwalder, Mathias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787138/ https://www.ncbi.nlm.nih.gov/pubmed/23907631

Ejemplares similares

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
por: Knolle, Percy A., et al.
Publicado: (2021)

Viral hepatitis and liver cancer
por: Ringehan, Marc, et al.
Publicado: (2017)

Treating fatty liver and insulin resistance
por: Perry, Rachel J., et al.
Publicado: (2013)

Correction to ‘Viral hepatitis and liver cancer’
por: Ringelhan, Marc, et al.
Publicado: (2018)

Immunological functions of liver sinusoidal endothelial cells
por: Knolle, Percy A, et al.
Publicado: (2016)

Adoptive cell therapy and modulation of the tumour microenvironment: new insights from ASCO 2016
por: Khoja, Leila, et al.
Publicado: (2016)

Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
por: Çakmak-Görür, Neşe, et al.
Publicado: (2019)

The role of liver sinusoidal cells in local hepatic immune surveillance
por: Wohlleber, Dirk, et al.
Publicado: (2016)

Outcome of Antiviral Immunity in the Liver Is Shaped by the Level of Antigen Expressed in Infected Hepatocytes
por: Manske, Katrin, et al.
Publicado: (2018)

Linear B-Cell Epitopes in Human Norovirus GII.4 Capsid Protein Elicit Blockade Antibodies
por: Moeini, Hassan, et al.
Publicado: (2021)

Contribution of Liver Nonparenchymal Cells to Hepatic Fibrosis: Interactions with the Local Microenvironment
por: Fausther, Michel, et al.
Publicado: (2017)

The Liver Cancer Immune Microenvironment: Emerging Concepts for Myeloid Cell Profiling with Diagnostic and Therapeutic Implications
por: Arvanitakis, Konstantinos, et al.
Publicado: (2023)

Year in review: Liver cancer research in 2022: tumor microenvironment takes the central stage
por: Liao, Weiting, et al.
Publicado: (2023)

Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
por: Luedemann, Max, et al.
Publicado: (2022)

High precision-cut liver slice model to study cell-autonomous antiviral defense of hepatocytes within their microenvironment
por: Brugger, Marcus, et al.
Publicado: (2022)

Platelets in chronic liver disease, from bench to bedside
por: Ramadori, Pierluigi, et al.
Publicado: (2019)

In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity
por: Manske, Katrin, et al.
Publicado: (2021)

Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B
por: Klopp, Alexandre, et al.
Publicado: (2021)

Liver Cancer: Improving Standard Diagnosis and Therapy
por: Masuzaki, Ryota
Publicado: (2023)

Radiotherapy: the key to immunotherapy ignition?
por: Luterstein, Elaine, et al.
Publicado: (2017)

Tracking the T-cell repertoire after adoptive therapy
por: Watkins, Thomas S, et al.
Publicado: (2017)

Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy
por: Buxton, Alison K., et al.
Publicado: (2022)

Liver X receptor activation promotes differentiation of regulatory T cells
por: Herold, Martin, et al.
Publicado: (2017)

Intrinsic and environmental factors in intrahepatic cholangiocarcinoma development
por: Yuan, Detian, et al.
Publicado: (2017)

TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different Mechanisms
por: Stefanescu, Cristina, et al.
Publicado: (2021)

Allogeneic adoptive cell transfer therapy as a potent universal treatment for cancer
por: Marcus, Assaf, et al.
Publicado: (2011)

Biomarkers of bacterial translocation in advanced chronic liver disease: the key to individualizing prognosis
por: Majumdar, Avik, et al.
Publicado: (2016)

Cautiously using natural medicine to treat liver problems
por: Xiong, Fei, et al.
Publicado: (2017)

Treating Nonalcoholic Fatty Liver Disease From the Outside In?
por: Flynn, Charles R.
Publicado: (2019)

A breakthrough in liver regeneration for treatment of liver cancer
por: Xu, Hao, et al.
Publicado: (2021)

The immune microenvironment as a guide for cancer therapies
por: Fridman, Wolf H.
Publicado: (2012)

The Prometastatic Microenvironment of the Liver
por: Vidal-Vanaclocha, Fernando
Publicado: (2008)

Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24(high)CD38(high) Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders
por: Körber, Nina, et al.
Publicado: (2021)

Complementary and Alternative Therapies for Liver Diseases
por: Guan, Yong-Song, et al.
Publicado: (2013)

Endothelial chemokine receptors as facilitators of tumor cell extravasation?
por: Hoos, Alexandra, et al.
Publicado: (2012)

From CARs to TRUCKs and Beyond: Safely en Route to Adoptive T-cell Therapy for Cancer
por: Dummy
Publicado: (2016)

What are the key points in the association between the gut microbiome and nonalcoholic fatty liver disease?
por: Vallianou, Natalia, et al.
Publicado: (2019)

Pyruvate Dehydrogenase Kinase 4: A Key Mediator for Metabolic Regulation of Liver Regeneration
por: Burdick, James, et al.
Publicado: (2020)

Vitamin A in Nonalcoholic Fatty Liver Disease: A Key Player in an Offside Position?
por: Berasain, Carmen, et al.
Publicado: (2020)

Fat, cancer, the gut-liver axis and rare liver diseases
por: Berenguer, Marina
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e3o8cmv5f3vnb8n53d57g6urm3